BPC 157 SolXGenix BPC 157 Banned: Key Facts on the Latest FDA Decision BPC 157 Peptide Therapy Advanced Healing & Regeneration FDA's Overreach on Compounded Peptides Regulatory Alert: FDA's April 2026 Update on BPC 157 and GHK Cu Holt Law The U.S. Food and Drug Administration is moving toward allowing compounding pharmacies to produce more than a dozen injectable peptides that were banned because of potentially significant safety risks, the New York